Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection

  title={Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection},
  author={Jerry A. Nick and Rebekah M. Dedrick and Alice L. Gray and E. Vladar and Bailey E. Smith and Krista G Freeman and Kenneth C. Malcolm and L. Elaine Epperson and Nabeeh A. Hasan and Jo Hendrix and Kimberly Callahan and Kendra Walton and Brian E. Vestal and Emily Wheeler and Noel Rysavy and Katie R. Poch and Silvia Marcela C{\'a}ceres and V. Lovell and Katherine B. Hisert and Vinicius Calado Nogueira de Moura and Delphi Chatterjee and Prithwiraj De and Natalia Weakly and Stacey L. Martiniano and David A Lynch and Charles L. Daley and Michael Strong and Fan Jia and Graham F. Hatfull and Rebecca M. Davidson},

Figures from this paper

Alternatives to Antibiotics against Mycobacterium abscessus

This review summarizes recent research on different strategies such as host modulation using stem cells, photodynamic therapy, antibiofilm therapy, phage therapy, nanoparticles, vaccines and antimicrobial peptides against M. abscessus both in vitro and in vivo.

Imaging the Infection Cycle of T7 at the Single Virion Level

TIRF microscopy was used to uncover the spatial dynamics of the target recognition and binding by individual T7 phage particles and revealed that genome release is mechanically controlled to prevent premature delivery of host-lysis genes.

Complete Genome Sequences of Mycobacterium smegmatis Phages MelsMeow, Yorick, Virgeve, and Mikro

Mycobacterium phages Mikro, Yorick, Virgeve, and MelsMeow were isolated from soil in Rock Hill, South Carolina. Mikro is a myovirus with a comparatively large genome of 157,166 bp. The remainder are

Genome Sequences and Characteristics of Six Cluster B1 Mycobacteriophages Discovered at Saint Joseph’s University

We report on six new siphoviruses infecting Mycobacterium smegmatis that were isolated from soil samples collected on the campus of Saint Joseph’s University, on the western edge of Philadelphia,

From Farm to Fork: Streptococcus suis as a Model for the Development of Novel Phage-Based Biocontrol Agents

The prevalence of prophages and the anti-viral defence arsenal in the genome of the pathogen is described as a means to define the genetic building blocks that are available for the (synthetic) development of phage-based treatments.

Modelling infectious disease to support human health

  • D. M. Tobin
  • Medicine, Biology
    Disease models & mechanisms
  • 2022
During the current COVID-19 pandemic, there has been renewed scientific and public focus on understanding the pathogenesis of infectious diseases and investigating vaccines and therapies to combat them, but fundamental and translational research on other pathogens and host immunity must be pursued.

Engineered Bacteriophages Containing Anti-CRISPR Suppress Infection of Antibiotic-Resistant P. aeruginosa

Evidence is provided that engineered phages may be an alternative, viable approach by which to treat patients with an intractable bacterial infection, especially an infection by clinically MDR bacteria that are unresponsive to conventional antibiotic therapy.

Complete Genome Sequence of Finnry, a Subcluster L3 Mycobacteriophage from Charleston, South Carolina

The genome of this temperate siphovirus is 75,632 bp long (130 predicted protein-coding genes, 9 tRNAs, and no transfer-messenger RNAs), and BLASTn alignment revealed 99.86% identity with the genome of L3 mycobacteriophage Samty.

Mycobacteriophages: From Petri dish to patient

The genomic insights and engineering tools have facilitated exploration of phages for treatment of Mycobacterium infections, although their full therapeutic potential has yet to be realized.

Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis

Subclass analysis suggests that IgG3 is the predominant subtype in these subjects with chronic bacterial infections suggesting a defect in class maturation, which could be useful to monitor M. abscessus group infections in chronic lung disease as an adjunct or alternative to culture.



Mycobacterium abscessus Strain Morphotype Determines Phage Susceptibility, the Repertoire of Therapeutically Useful Phages, and Phage Resistance

The phage infection profiles of 82 M. abscessus recent clinical isolates are determined and it is found that colony morphotype—rough or smooth—is a key indicator of phage susceptibility.

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

  • C. DaleyJ. Iaccarino K. Winthrop
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2020
This guideline focuses on pulmonary disease in adults (without cystic fibrosis or human immunodeficiency virus infection) caused by the most common NTM pathogens such as Mycobacterium avium complex, MycOBacterium kansasii, and Myc Cobacterium xenopi among the slowly growing NTM and MyCobacterius abscessus among the rapidly growing N TM.

Engineered bacteriophages for treatment of a patient with a disseminated drug resistant Mycobacterium abscessus

Intravenous phage treatment was well tolerated and associated with objective clinical improvement, including sternal wound closure, improved liver function, and substantial resolution of infected skin nodules.

Stepwise pathogenic evolution of Mycobacterium abscessus

Using graphical pan-genome analysis, this work found that horizontal gene transfer—particularly gene transfer of global transcriptional regulators—can provide an important mechanism for creating large phenotypic variance in environmental M. abscessus isolates, consequently enabling saltational evolution toward enhanced human infectivity.

Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States

It is demonstrated the safety and feasibility of intravenous BT for a variety of infections and practical considerations that will be critical for informing future clinical trials are discussed.

Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10

The BEAST software package unifies molecular phylogenetic reconstruction with complex discrete and continuous trait evolution, divergence-time dating, and coalescent demographic models in an efficient statistical inference engine using Markov chain Monte Carlo integration.

Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7

The software package Tracer is presented, for visualizing and analyzing the MCMC trace files generated through Bayesian phylogenetic inference, which provides kernel density estimation, multivariate visualization, demographic trajectory reconstruction, conditional posterior distribution summary, and more.

Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group

An improved decontamination method has been demonstrated to reduce overgrowth of mycobacterial media by Pseudomonas aeruginosa and allow the successful recovery of nontuberculous mycobacteria (NTM)